Chelsea Norcross
Surgical · Rochester, NYNPI 1023128709
Payments from drug & device makers
Across 57 payments — averaging $57.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Baxter Healthcare$860
- Mimedx Group, Inc.$171
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$147
- Boston Scientific$141
- Johnson & Johnson$130
- plus $594 from 11 others
What the payments were for
- Travel & lodging$94729%
- Food & beverage$2,30371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $1,207 |
| Baxter Healthcare | 18 | $860 |
| Mimedx Group, Inc. | 1 | $171 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $147 |
| Boston Scientific | 1 | $141 |
| Johnson & Johnson | 2 | $130 |
| Getinge USA Sales, LLC | 3 | $117 |
| Lexicon Pharmaceuticals, Inc. | 1 | $112 |
| Terumo Cardiovascular Systems Corporation | 1 | $71 |
| Atricure, Inc. | 3 | $66 |
| Kestra Medical Technology Services, Inc. | 1 | $61 |
| Pfizer | 2 | $47 |
| KCI USA, Inc. | 1 | $34 |
| Novartis | 1 | $24 |
| Bolton Medical Inc | 1 | $22 |
| Edwards Lifesciences | 1 | $22 |
| Smith+Nephew | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,250 in reported general payments places this provider in the 90th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 24 | $278 |
| ClopidogrelClopidogrel Bisulfate | 39 | $264 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $176 |
| Atorvastatin Calcium | 18 | $158 |
| Metoprolol Succinate | 11 | $124 |
| Warfarin Sodium | 16 | $116 |
| Metoprolol Tartrate | 23 | $71 |
Paid to pharmacies, not to this prescriber.
Other surgical in Rochester
- John DelisioRochester$17K
- Jane CichelliRochester$11K
- Candi NapolitanoRochester$11K
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Sarah MartineckWilliamsville$87K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.